MarketInOut Stock Screener Log In | Sign Up

Gerresheimer AG

XETRA • Healthcare • Medical Instruments & Supplies • Quote as of 10/28/2026 09:03
Gerresheimer AG stock price and volume chart

Company Profile

IndustryMedical Instruments & Supplies
SectorHealthcare
ExchangeXETRA
Market Capitalization1,082.48 mln
Float34.54 mln
Earnings Date10/30/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-3.2
Reliable

Relative Strength

98 / 100
Top performer

Debt / Equity

2.31
Very high leverage

Pre-Tax Margin

-17%
Loss-making

ROE

-31.34
Deeply negative

Business Description

Founded in 1864 and headquartered in Düsseldorf, Germany, Gerresheimer AG is a global manufacturer of specialized packaging and drug delivery systems for the healthcare and life sciences industries. The company produces a wide range of glass and plastic products, including syringes, vials, ampoules, inhalers, and injectors, serving pharmaceutical, biotech, and medical technology customers worldwide. Gerresheimer also supplies diagnostic devices, cosmetic packaging, and laboratory products, making it a broad partner across multiple industries from healthcare to food and beverage.

Key Fundamentals

EPS-11.86
ROE-31.34
RPS67.09
ROIC-2.11
ROA-8.63
Interest Cover-3.66
EBITDA, mln226
EV / EBITDA13.62
EV / EBIT-10.20
Revenue, mln2,276
EV / Revenue1.35

Quote Details

Last 32.48
Change -0.12 (-0.37%)
Open 32.36
Volume 915
Turnover 29,719
Average Volume 168,277

Financial Ratios

Pre-Tax Profit Margin-17
Leverage Ratio4.55
Current Ratio1.07
Price / Book1.10
Price / Cash Flow4.14
Price / Free Cash Flow134
Debt / Equity2.31
Price / Sales0.47
PEG Ratio1.23

Financial Strength

Altman Z-Score0.76
Piotroski F-Score 4 / 9
Beneish M-Score-3.2
Price to Intrinsic Value2.86
Shiller PE Ratio13.20

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.25% 82 / 100   
1 Month 18.37% 98 / 100   
2 Months 23.59% 97 / 100   
6 Months 26.09% 94 / 100   
1 Year 12.62% 55 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog